# Editas Medicine, Inc.: Form 8-K, filed Nov 2, 2022

- Company: [Editas Medicine, Inc.](/companies/edit.md) (CIK 1650664)
- Form: 8-K
- Filed: 2022-11-02
- Accepted by EDGAR: Nov 2, 2022, 06:49 ET
- Period: 2022-11-02
- Accession: 0001558370-22-015898
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1650664/000155837022015898/edit-20221102x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650664/000155837022015898/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650664/000155837022015898/edit-20221102x8k.htm

Filed Nov 2, 2022.
Source: SEC EDGAR, the filing index for accession 0001558370-22-015898. Last ingested by Listed: Oct 27, 2026, 17:28 ET. No prices; not investment advice.